PT967207E - Novos derivados de nitrona processo para a sua preparacao e as composicoes farmaceuticas que os contem - Google Patents

Novos derivados de nitrona processo para a sua preparacao e as composicoes farmaceuticas que os contem

Info

Publication number
PT967207E
PT967207E PT99401565T PT99401565T PT967207E PT 967207 E PT967207 E PT 967207E PT 99401565 T PT99401565 T PT 99401565T PT 99401565 T PT99401565 T PT 99401565T PT 967207 E PT967207 E PT 967207E
Authority
PT
Portugal
Prior art keywords
new
preparation
contain
pharmaceutical compositions
derivatives process
Prior art date
Application number
PT99401565T
Other languages
English (en)
Inventor
Alain Dhainaut
Pierre Lestage
Andre Tizot
Brian Lockhart
Solo Goldstein
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of PT967207E publication Critical patent/PT967207E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT99401565T 1998-06-26 1999-06-24 Novos derivados de nitrona processo para a sua preparacao e as composicoes farmaceuticas que os contem PT967207E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9808116A FR2780404B1 (fr) 1998-06-26 1998-06-26 Nouveaux derives de nitrone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
PT967207E true PT967207E (pt) 2002-12-31

Family

ID=9527896

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99401565T PT967207E (pt) 1998-06-26 1999-06-24 Novos derivados de nitrona processo para a sua preparacao e as composicoes farmaceuticas que os contem

Country Status (17)

Country Link
US (1) US6034250A (pt)
EP (1) EP0967207B1 (pt)
JP (1) JP2000026428A (pt)
CN (1) CN1153766C (pt)
AT (1) ATE223904T1 (pt)
AU (1) AU747203B2 (pt)
BR (1) BR9903282A (pt)
CA (1) CA2274621C (pt)
DE (1) DE69902851T2 (pt)
DK (1) DK0967207T3 (pt)
ES (1) ES2183492T3 (pt)
FR (1) FR2780404B1 (pt)
HU (1) HUP9902199A1 (pt)
NO (1) NO312722B1 (pt)
NZ (1) NZ336460A (pt)
PT (1) PT967207E (pt)
ZA (1) ZA994201B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096899A (en) * 1998-04-14 2000-08-01 The Regents Of The University Of Michigan Cylic imidazole compounds having relatively low hydrogen content and relatively high nitrogen content and polymers formed therefrom
KR100986225B1 (ko) * 2001-02-16 2010-10-07 아스비오파마 가부시키가이샤 Aop-1 유전자 또는 aop-1의 발현 감소를수반하는 질환의 치료 방법 및 상기 질환의 치료약
WO2003010154A1 (en) * 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses
EP1482931B1 (en) * 2002-03-05 2011-10-19 TransTech Pharma, Inc. Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
AU2003230770A1 (en) * 2002-03-28 2003-10-13 Oxis International, Inc. Neuroprotectant methods, compositions, and screening methods thereof
EP1635823A1 (en) * 2003-05-20 2006-03-22 TransTech Pharma Inc. Rage antagonists as agents to reverse amyloidosis and diseases associated therewith
CN101468970B (zh) 2008-04-25 2011-05-11 暨南大学 一种硝酮类化合物及其制备方法和在制药中的应用
EP2470510B1 (en) 2009-09-30 2014-05-14 TransTech Pharma, LLC Substituted imidazole derivatives for treatment of alzheimers disease.
JP5885620B2 (ja) * 2012-08-22 2016-03-15 四国化成工業株式会社 2−(2−フリル)イミダゾール化合物及び酸化防止剤
FR3012460B1 (fr) 2013-10-25 2015-12-11 Michelin & Cie Composition de caoutchouc comprenant un elastomere dienique portant des fonctions imidazole reparties de facon aleatoire le long de la chaine
FR3012451B1 (fr) 2013-10-25 2016-11-11 Michelin & Cie Compose 1,3-dipolaire portant une fonction imidazole
FR3012458B1 (fr) * 2013-10-25 2015-10-30 Michelin & Cie Composition de caoutchouc comprenant un additif compose 1,3-dipolaire portant une fonction imidazole

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0643403B2 (ja) * 1986-01-25 1994-06-08 四国化成工業株式会社 イミダゾール―アルドキシム化合物の合成方法
US4803282A (en) * 1986-08-27 1989-02-07 Pennwalt Corporation Alpha-substituted ketonitrone derivatives
ATE209908T1 (de) * 1991-06-18 2001-12-15 Oklahoma Med Res Found RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN
US5455272A (en) * 1993-10-22 1995-10-03 Oklahoma Medical Research Foundation Spin trap nitronyl hindered phenols
WO1997019054A1 (en) * 1995-11-17 1997-05-29 Florida International University Azulenyl nitrone spin trapping agents, methods of making and using same

Also Published As

Publication number Publication date
EP0967207B1 (fr) 2002-09-11
AU3680099A (en) 2000-01-13
NZ336460A (en) 2000-05-26
CN1153766C (zh) 2004-06-16
US6034250A (en) 2000-03-07
DE69902851T2 (de) 2003-05-28
HUP9902199A1 (hu) 2000-06-28
NO993122D0 (no) 1999-06-23
CA2274621A1 (fr) 1999-12-26
CA2274621C (fr) 2004-01-20
BR9903282A (pt) 2000-04-18
ZA994201B (en) 2000-01-11
JP2000026428A (ja) 2000-01-25
FR2780404B1 (fr) 2001-04-13
CN1245169A (zh) 2000-02-23
FR2780404A1 (fr) 1999-12-31
AU747203B2 (en) 2002-05-09
NO312722B1 (no) 2002-06-24
EP0967207A1 (fr) 1999-12-29
ES2183492T3 (es) 2003-03-16
DK0967207T3 (da) 2003-01-20
ATE223904T1 (de) 2002-09-15
DE69902851D1 (de) 2002-10-17
NO993122L (no) 1999-12-27
HU9902199D0 (en) 1999-08-30

Similar Documents

Publication Publication Date Title
PT967207E (pt) Novos derivados de nitrona processo para a sua preparacao e as composicoes farmaceuticas que os contem
MX9204746A (es) Nuevos derivados de tiazolilbenzofuranos, procedimientos para la preparacion de los mismos y las composiciones farmaceuticas que los contienen.
PT94925A (pt) Processo para a preparacao de derivados de tiazol e de composicoes farmaceuticas que os contem
ES2088933T3 (es) Derivados de pirazol, procedimientos para su preparacion y composicion farmaceutica que los contiene.
AR058967A2 (es) Derivados de triazolo[4,5-d] pirimidina composiciones farmaceuticas que los contienen y proceso de preparacion para dichos compuestos
MX9202142A (es) Nuevos derivados de urea, proceso para su preparacion, y composicion farmaceutica que los comprende.
BR8400887A (pt) Processo para a preparacao de derivados de guanidina,composicoes herbicidas,composicoes reguladoras do crescimento de plantas,aplicacoes dos ditos derivados,e processo para a preparacao de tais composicoes
NO912630L (no) Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler som antiarteriosklerotiske midler
ES2176204T3 (es) Antidepresivos que contienen un derivado de xantina.
AR042273A1 (es) Derivados de pirazol, procedimiento para prepararlos y las composiciones farmaceuticas que los contienen
PT96916A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um macrolido
ES549542A0 (es) Un procedimiento para preparar nuevos derivados de benzo- triazol- y benzoxazolamina
BR9909739A (pt) Benzotiadiazóis e derivados
IT1171880B (it) Derivati di 2-ammino-3-acilammino-6-benzilammino-piridina aventi azione antiepilettica e procedimento per la loro produzione
BR9802804A (pt) Compostos benzimidazol, benzoxazol e benzotiazol, processo para sua preparação e composições farmacéuticas contendo os mesmos.
BR1100991A (pt) Compostos, processo para preparação dos mesmos, medicamentos, e, compostos intermediários
GB9718903D0 (en) Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
PT83725B (pt) Processo para preparacao de novos derivados da 3-oxadiol-beta-carbolina e 3-carboxilato-beta-carbolina e de composicoes farmaceuticas que os contem
DE69323667D1 (de) 4-substituierte 1,2,4-Triazolderivate
PT89643A (pt) Processo para a preparacao de derivados de 2-{(4-piperidinil)-metil}-1,2,3,4-tetrahidro-isoquinoleina e de composicoes farmaceuticas que os contem
PT97991A (pt) Processo para a preparacao de derivados de 2-(aminoalquil)-5-(arilalquil)-1,3-dioxanos e de composicoes farmaceuticas que os contem
BR9502079A (pt) Composto,formulação farmaceutica e processo para preparar um composto
FI874789A0 (fi) Menetelmä valmistaa farmakologisesti aktiivisia substituoituja 1H-imidatsoleja
DK0447116T3 (da) Urinstof-derivater, deres fremstilling samt lægemidler indeholdende sådanne derivater
PT1257552E (pt) Derivados de xantina, intermediarios e aplicacao ao tratamento de osteoporose